01 1Cambrex Charles City, Inc.
01 1RPT193-1 Hemi-Tartrate
01 1U.S.A
NDC Package Code : 59116-7320
Start Marketing Date : 2019-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
95
PharmaCompass offers a list of Zelnecirnon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zelnecirnon manufacturer or Zelnecirnon supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zelnecirnon manufacturer or Zelnecirnon supplier.
PharmaCompass also assists you with knowing the Zelnecirnon API Price utilized in the formulation of products. Zelnecirnon API Price is not always fixed or binding as the Zelnecirnon Price is obtained through a variety of data sources. The Zelnecirnon Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A RPT193 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RPT193, including repackagers and relabelers. The FDA regulates RPT193 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RPT193 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A RPT193 supplier is an individual or a company that provides RPT193 active pharmaceutical ingredient (API) or RPT193 finished formulations upon request. The RPT193 suppliers may include RPT193 API manufacturers, exporters, distributors and traders.
click here to find a list of RPT193 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing RPT193 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for RPT193 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture RPT193 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain RPT193 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a RPT193 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of RPT193 suppliers with NDC on PharmaCompass.
We have 1 companies offering RPT193
Get in contact with the supplier of your choice:
